Detalles de la búsqueda
1.
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
J Immunother Cancer;
11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37586765
2.
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy.
Mol Ther Oncolytics;
24: 417-428, 2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35141398
3.
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma.
J Immunother Cancer;
9(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34210820
4.
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
J Immunother Cancer;
9(10)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34607899
5.
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer.
Oncotarget;
11(22): 2092-2105, 2020 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32547707
6.
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.
Transplant Res;
2(1): 17, 2013 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24160259
Resultados
1 -
6
de 6
1
Próxima >
>>